{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:12:48Z","timestamp":1740136368394,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10072-024-07852-7","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T14:55:42Z","timestamp":1730300142000},"page":"1415-1417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clozapine for Parkinson\u2019s disease psychosis in a septuagenarian: a nightmare turned into bliss"],"prefix":"10.1007","volume":"46","author":[{"given":"Janki","family":"Makani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5224-2808","authenticated-orcid":false,"given":"Deepika","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"7852_CR1","doi-asserted-by":"publisher","first-page":"238Y241","DOI":"10.1136\/jnnp.2008.152579","volume":"8","author":"W Poewe","year":"2008","unstructured":"Poewe W (2008) When a Parkinson\u2019s disease patient starts to hallucinate. Pract Neurol 8:238Y241","journal-title":"Pract Neurol"},{"key":"7852_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJM199903113401003","volume":"340","author":"The Parkinson Study Group","year":"1999","unstructured":"The Parkinson Study Group (1999) Low dose clozapine for the treatment of drug-induced psychosis in Parkinson\u2019s disease. N Engl J Med 340:757\u2013763","journal-title":"N Engl J Med"},{"issue":"2","key":"7852_CR3","doi-asserted-by":"publisher","first-page":"201Y211","DOI":"10.1002\/1531-8257(200003)15:2<201::AID-MDS1001>3.0.CO;2-D","volume":"15","author":"JH Friedman","year":"2000","unstructured":"Friedman JH, Factor SA (2000) Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson\u2019s disease. Mov Disord 15(2):201Y211","journal-title":"Mov Disord"},{"key":"7852_CR4","doi-asserted-by":"publisher","first-page":"958Y963","DOI":"10.1002\/mds.20474","volume":"20","author":"WG Ondo","year":"2005","unstructured":"Ondo WG, Tinter R, Voung KD et al (2005) Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson\u2019s disease. Mov Disord 20:958Y963","journal-title":"Mov Disord"},{"key":"7852_CR5","doi-asserted-by":"publisher","first-page":"313Y318","DOI":"10.1002\/mds.21116","volume":"22","author":"JM Rabey","year":"2007","unstructured":"Rabey JM, Prokhorov T, Minovitz A et al (2007) Effect of quetiapine in psychotic Parkinson\u2019s disease patients: a double-blind labeled study of 3 months duration. Mov Disord 22:313Y318","journal-title":"Mov Disord"},{"key":"7852_CR6","first-page":"689Y695","volume":"75","author":"P Pollack","year":"2004","unstructured":"Pollack P, Tison F, Rascol O et al (2004) Clozapine in drug induced psychosis in Parkinson\u2019s disease: a randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry 75:689Y695","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7852_CR7","first-page":"1077Y1081","volume":"4","author":"JH Friedman","year":"1997","unstructured":"Friedman JH, Koller WC, Lannon MC et al (1997) Benztropine versus clozapine for the treatment of tremor in Parkinson\u2019s disease. Neurology 4:1077Y1081","journal-title":"Neurology"},{"issue":"1","key":"7852_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1192\/bjb.2018.67","volume":"43","author":"S Farooq","year":"2019","unstructured":"Farooq S, Choudry A, Cohen D, Naeem F, Ayub M (2019) Barriers to using clozapine in treatment-resistant schizophrenia: systematic review. BJPsych Bull 43(1):8\u201316. https:\/\/doi.org\/10.1192\/bjb.2018.67Epub 2018 Sep 28. PMID: 30261942; PMCID: PMC6327301","journal-title":"BJPsych Bull"},{"key":"7852_CR9","doi-asserted-by":"crossref","unstructured":"Silva E, Legge S, Casetta C, Whiskey E, Oloyede E, Gee S Understanding clozapine-related blood dyscrasias. Developments, genetics, ethnicity and disparity: it\u2019s a CIN. BJPsych Bull. 2024 Jun 3:1\u20136. doi: 10.1192\/bjb.2024.38. Epub ahead of print. PMID: 38828731","DOI":"10.1192\/bjb.2024.38"},{"issue":"2","key":"7852_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/acps.12898","volume":"138","author":"N Myles","year":"2018","unstructured":"Myles N, Myles H, Xia S, Large M, Kisely S, Galletly C, Bird R, Siskind D (2018) Meta-analysis examining the epidemiology of clozapine-associated neutropenia. Acta Psychiatr Scand 138(2):101\u2013109. https:\/\/doi.org\/10.1111\/acps.12898Epub 2018 May 21. PMID: 29786829","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"7852_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/mdc3.12266","volume":"3","author":"TK Yaw","year":"2016","unstructured":"Yaw TK, Fox SH, Lang AE (2016) Clozapine in Parkinsonian Rest Tremor: a review of outcomes, adverse Reac ons, and possible mechanisms of Ac on. Mov Disord Clin Pract 3(2):116\u2013124","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"7852_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1212\/01.WNL.0000110317.52453.6C","volume":"62","author":"F Durif","year":"2004","unstructured":"Durif F, Debilly B, Galitzky M, Morand D, Viallet F, Borg M, Thobois S, Broussolle E, Rascol O (2004) Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study. Neurology 62(3):381\u2013388","journal-title":"Neurology"},{"key":"7852_CR13","doi-asserted-by":"publisher","unstructured":"Thames BH, Ondo WG (2023) Clozapine: Efficacy for Parkinson Disease psychosis in patients refractory to pimavanserin. Parkinsonism Relat Disord. ;109:105356. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105356. Epub 2023 Mar 5. PMID: 36905718","DOI":"10.1016\/j.parkreldis.2023.105356"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07852-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07852-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07852-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T19:00:47Z","timestamp":1739559647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07852-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["7852"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07852-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient and her attendant provided informed consent for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors confirm that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable as it was a single case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}